Strata Critical Medical CEO RSU tax share withholding

Strata Critical Medical, Inc. reported a Form 4 for officer Scott M. Wunsch, CEO of Trinity Air Medical.

Rhea-AI Filing Summary

Strata Critical Medical, Inc. reported a Form 4 for officer Scott M. Wunsch, CEO of Trinity Air Medical. On March 8, 2026, 3,631 shares of Class A common stock were withheld by the company to cover tax obligations from restricted stock unit vesting, a non-market disposition. After this, Wunsch held 569,807 shares directly and 382,987 shares indirectly through a limited liability company of which he is the sole member.

Insider Trade Summary

Exercise Price or Tax Liability: 3,631 shares

Exercise Price or Tax Liability 2 txns

Insider Wunsch Scott M

Role CEO, Trinity Air Medical

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Class A common stock, $0.0001 par value per share	3,631	$4.54	$16K
holding	Class A common stock, $0.0001 par value per share	--	--	--

Holdings After Transaction: Class A common stock, $0.0001 par value per share — 569,807 shares (Direct); Class A common stock, $0.0001 par value per share — 382,987 shares (Indirect, See Footnotes)

Footnotes (2)

1. F1. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
2. F2. Held directly by a limited liability company of which the Reporting Person is the sole member.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Strata Critical Medical (SRTA) report for Scott M. Wunsch?

Strata Critical Medical reported a Form 4 for Scott M. Wunsch showing 3,631 shares of Class A common stock withheld by the company to satisfy tax obligations from restricted stock unit vesting, rather than an open-market sale, on March 8, 2026.

How many Strata Critical Medical (SRTA) shares were withheld for taxes in this Form 4?

The Form 4 shows that 3,631 shares of Strata Critical Medical Class A common stock were withheld by the issuer to cover tax withholding obligations arising from the vesting of restricted stock units, as described in the filing’s footnotes.

How many Strata Critical Medical (SRTA) shares does Scott M. Wunsch hold after this transaction?

After the tax-withholding disposition, Scott M. Wunsch held 569,807 shares of Strata Critical Medical Class A common stock directly, and a separate holding entry shows 382,987 shares held indirectly through a limited liability company associated with him.

Was the Strata Critical Medical (SRTA) insider transaction an open-market sale?

No, the transaction was not an open-market sale. The 3,631 shares were withheld by Strata Critical Medical to satisfy tax withholding obligations linked to restricted stock unit vesting, a routine compensation-related disposition rather than a discretionary sale in the market.

How are indirect holdings reported for Scott M. Wunsch at Strata Critical Medical (SRTA)?

Indirect holdings are reported as 382,987 shares of Class A common stock held by a limited liability company of which Scott M. Wunsch is the sole member, as noted in the footnotes, indicating his beneficial interest through that entity.

What does transaction code F mean in the Strata Critical Medical (SRTA) Form 4?

Transaction code F in this Form 4 indicates shares delivered to the issuer to satisfy tax withholding or exercise-price obligations. Here, it reflects 3,631 shares withheld by Strata Critical Medical to cover tax obligations from restricted stock unit vesting for Scott M. Wunsch.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/10/2026 - 05:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wunsch Scott M

(Last) (First) (Middle)

C/O STRATA CRITICAL MEDICAL, INC.

31 HUDSON YARDS, 14TH FLOOR

(Street)

NEW YORK NY 10001

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, Trinity Air Medical

3. Date of Earliest Transaction (Month/Day/Year)
03/08/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A common stock, $0.0001 par value per share	03/08/2026		F		3,631(1)	D	$4.54	569,807	D
Class A common stock, $0.0001 par value per share								382,987	I(2)	See Footnotes

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

2. Held directly by a limited liability company of which the Reporting Person is the sole member.

Remarks:

	/s/ Melissa M. Tomkiel, Attorney-in-fact for Scott M. Wunsch	03/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.